Galectin-3 expression in various thyroid neoplasms and its possible role in metastasis formation
Citation
K. Kawachi et al., Galectin-3 expression in various thyroid neoplasms and its possible role in metastasis formation, HUMAN PATH, 31(4), 2000, pp. 428-433
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Journal title
HUMAN PATHOLOGY
SICI code
0046-8177(200004)31:4<428:GEIVTN>2.0.ZU;2-A
Abstract
Galectin-3 is a member of the beta-galactoside-binding protein family that
plays an important role in cell-cell adhesion and in cell-matrix interactio
n. We have examined the expression of galectin-3 in normal, adenomatous, an
d malignant thyroid tissues and also in metastatic lesions. Galectin-3 was
rarely expressed in normal thyroid tissue but was abundant in the cytoplasm
of the neoplastic lesions. Among neoplastic lesions, galectin-3 was expres
sed to a greater extent in follicular carcinomas than in follicular adenoma
s and was present in greater amounts: in papillary carcinomas than in folli
cular adenomas or carcinomas. Primary lesions of papillary carcinoma with m
etastasis contained significantly higher concentrations of galectin-3 than
tumors of this type without metastases. However, the expression of galectin
-3 was significantly decreased in metastatic lesions in the lymph nodes com
pared with their primary lesions. From these results, we assumed that galec
tin-3 works in different ways at different stages of thyroid neoplasm proli
feration. Among primary tumors, galectin-3 expression is significantly diff
erent in 3 histological types. However, the continuity of progression among
these tumors is not yet proven. In later stages, decreased expression of g
alectin-3 may aid the release of cancer cells from the primary lesions for
invasion and metastasis. HUM PATHOL 31:428-433, 2000. Copyright (C) 2000 by
W.B. Saunders Company.